{"DataElement":{"publicId":"2944515","version":"1","preferredName":"Adverse Event Severity Grade","preferredDefinition":"Numeric representation of the intensity/severity of an unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite).","longName":"AE_SEV_GD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2747735","version":"1","preferredName":"Adverse Event Severity/Intensity Scale for Adverse Events Severity Grade","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event.:Used of the degree of something undesirable e.g. pain or weather; also, strictness.:A position on a scale of intensity or amount or quality.","longName":"2235992v1.0:2747512v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2235992","version":"1","preferredName":"Adverse Event","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.","longName":"C41331","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-74E9-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-15","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-15","modifiedBy":"ONEDATA","dateModified":"2005-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2747512","version":"1","preferredName":"Severity/Intensity Scale for Adverse Events Severity Grade","preferredDefinition":"A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event.:Used of the degree of something undesirable e.g. pain or weather; also, strictness.:A position on a scale of intensity or amount or quality.","longName":"C49705:C25676:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severity/Intensity Scale for Adverse Events","conceptCode":"C49705","definition":"A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96BD65-9323-04F3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"ONEDATA","dateModified":"2008-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C96EECB-A4F2-437C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-05-06","endDate":null,"createdBy":"UMLLOADER_CAAERS","dateCreated":"2008-05-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2943992","version":"1","preferredName":"Adverse Event Severity Grade","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used._Severity; used of the degree of something undesirable e.g. pain or weather._A position on a scale of intensity or amount or quality.","longName":"AE_SEV_GD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0","valueDescription":"Absent Adverse Event","ValueMeaning":{"publicId":"2954507","version":"1","preferredName":"Absent Adverse Event","longName":"2954507","preferredDefinition":"Grade 0 is universally defined as absence of Adverse Events or within normal limits or values.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Absent Adverse Event","conceptCode":"C75533","definition":"The absence of adverse events or within normal limits or values.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76133F16-8657-48DB-E040-BB89AD431ACF","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76133F16-8670-48DB-E040-BB89AD431ACF","beginDate":"2002-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"1","valueDescription":"Mild Adverse Event","ValueMeaning":{"publicId":"2954508","version":"1","preferredName":"Mild Adverse Event","longName":"2954508","preferredDefinition":"An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTCAE v4 Grade 1","conceptCode":"C84263","definition":"An adverse event that is asymptomatic; or involves mild or minor symptoms; or is of marginal clinical relevance; or consists of clinical or diagnostic observations alone; or for which intervention is not indicated; or for which only non-prescription intervention is indicated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76133F16-867C-48DB-E040-BB89AD431ACF","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"MAESKEB","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76133F16-8694-48DB-E040-BB89AD431ACF","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"2","valueDescription":"Moderate Adverse Event","ValueMeaning":{"publicId":"2954509","version":"1","preferredName":"Moderate Adverse Event","longName":"2954509","preferredDefinition":"An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTCAE v4 Grade 2","conceptCode":"C84264","definition":"An adverse event for which only minimal, local, or noninvasive intervention (e.g. packing, cautery) is indicated; or that limits instrumental activities of daily living (ADLs, e.g., shopping, laundry, transportation, or ability to conduct finances).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76133F16-86A1-48DB-E040-BB89AD431ACF","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"MAESKEB","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76133F16-86B9-48DB-E040-BB89AD431ACF","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"3","valueDescription":"Severe Adverse Event","ValueMeaning":{"publicId":"2954510","version":"1","preferredName":"Severe Adverse Event","longName":"2954510","preferredDefinition":"An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CTCAE v4 Grade 3","conceptCode":"C84265","definition":"An adverse event that is medically significant but not life-threatening; or for which inpatient care or prolongation of hospitalization are indicated; or that is an important medical event that does not result in hospitalization, but may jeopardize the patient or may require intervention either to prevent hospitalization, to prevent the AE from becoming life-threatening or causing death; or that is disabling; or that results in persistent or significant disability, incapacity, or limitation of self care activities of daily living (ADLs, e.g., getting in and out of bed, dressing, eating, getting around inside, bathing, or using the toilet).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76133F16-86C6-48DB-E040-BB89AD431ACF","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"MAESKEB","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76133F16-86DE-48DB-E040-BB89AD431ACF","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"5","valueDescription":"Death Related to Adverse Event","ValueMeaning":{"publicId":"2660006","version":"1","preferredName":"Death Related to Adverse Event","longName":"2660006","preferredDefinition":"The termination of life associated with an adverse event.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death Related to Adverse Event","conceptCode":"C48275","definition":"The termination of life associated with an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"33BEA2A0-DEE4-6CE1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-25","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-25","modifiedBy":"GDEEN","dateModified":"2023-01-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"76133F16-872F-48DB-E040-BB89AD431ACF","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"},{"value":"4","valueDescription":"Life Threatening Adverse Event","ValueMeaning":{"publicId":"2954511","version":"1","preferredName":"Life Threatening Adverse Event","longName":"2954511","preferredDefinition":"An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Life Threatening Adverse Event","conceptCode":"C84266","definition":"An adverse event that has life-threatening consequences; for which urgent intervention is indicated; that puts the patient at risk of death at the time of the event if immediate intervention is not undertaken.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"76133F16-86EB-48DB-E040-BB89AD431ACF","latestVersionIndicator":"Yes","beginDate":"2009-10-16","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"MAESKEB","dateModified":"2021-04-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7613CEB7-F29C-3700-E040-BB89AD433D8D","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-10-16","modifiedBy":"ONEDATA","dateModified":"2009-10-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2944509","version":"1","preferredName":"Adverse Event Severity Adverse Event Grade","preferredDefinition":"Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:Severity; used of the degree of something undesirable e.g. pain or weather.:Any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, syndrome, or disease, temporally associated with the use of a medical product or procedure, regardless of whether or not it is considered related to the product or procedure (attribution of unrelated, unlikely, possible, probable, or definite). The concept refers to events that could be medical product related, dose related, route related, patient related, caused by an interaction with another therapy or procedure, or caused by opioid initiation or dose escalation. The term also is referred to as an adverse experience. The old term Side Effect is retired and should not be used.:A position on a scale of intensity or amount or quality.","longName":"C41331:C25676:C41331:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Severity","conceptCode":"C25676","definition":"Used of the degree of something undesirable e.g. pain or weather; also, strictness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"743C896C-1ED8-79F1-E040-BB89AD4359CF","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-23","modifiedBy":"ONEDATA","dateModified":"2009-09-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTCAE:Common TerminologyCriteria for Adverse Events","workflowStatus":"RELEASED","registrationStatus":"Application","id":"742DD56B-0FDF-A7E6-E040-BB89AD43063D","latestVersionIndicator":"Yes","beginDate":"2009-09-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-22","modifiedBy":"GDEEN","dateModified":"2023-03-01","changeDescription":"VD already released;  caAERS v2.0 model released.  8/13/12 jc Curated to support CTCAE v4.0 release.  D Reeves 9/22/09; Updated origin to support all version of CTCAE_02.08.18_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"11518160","version":"1","longName":"CTDC (Clinical Trial Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"13484613","version":"1","longName":"MATCHBox","context":"CRDC"},{"publicId":"13484614","version":"1","longName":"ECOG-ACRIN DD","context":"CRDC"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811951","version":"1","longName":"Adverse Events","context":"CTEP"}]},{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"},{"publicId":"10000677","version":"1","longName":"Adverse Events","context":"CCR"},{"publicId":"3248617","version":"1","longName":"CCR 2011 Template","context":"CCR"},{"publicId":"3248619","version":"1","longName":"Base Symptoms","context":"CCR"},{"publicId":"3248632","version":"1","longName":"Laboratory All","context":"CCR"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]},{"publicId":"2179692","version":"1","longName":"TYPE OF CATEGORY","context":"DCP","ClassificationSchemeItems":[{"publicId":"2957372","version":"1","longName":"Case Report Forms Version 3","context":"DCP"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"},{"publicId":"3308730","version":"1","longName":"MediData Rave Use","context":"CCR"},{"publicId":"3331757","version":"1","longName":"Protocol 10C0052D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2992453","version":"1","longName":"Candidate Reuse","context":"NCIP"}]},{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"2859992","version":"1","longName":"Adverse Events CRF","context":"NCIP"},{"publicId":"3943912","version":"1","longName":"All Mandatory CRF CDEs","context":"NCIP"}]},{"publicId":"2194255","version":"1","longName":"Type of Condition","context":"DCP","ClassificationSchemeItems":[{"publicId":"3303133","version":"1","longName":"Pomegranate - Prostate Cancer","context":"DCP"},{"publicId":"3110219","version":"1","longName":"MSC and L SeMet in Adult Men","context":"DCP"},{"publicId":"3114163","version":"1","longName":"Cholecalciferol and Genistein","context":"DCP"},{"publicId":"2812998","version":"1","longName":"Pioglitazone - Oral Leukoplakia","context":"DCP"},{"publicId":"2812551","version":"1","longName":"9cUAB30","context":"DCP"},{"publicId":"3152820","version":"1","longName":"Pioglitazone - Lung Pre-Surgical NSCLC","context":"DCP"},{"publicId":"3018782","version":"1","longName":"Resveratrol in Postmenopausal Women","context":"DCP"},{"publicId":"3018781","version":"1","longName":"Metformin Colorectal Cancer","context":"DCP"},{"publicId":"3528035","version":"1","longName":"Docosahexaenoic Acid","context":"DCP"},{"publicId":"3182878","version":"1","longName":"Vitamin D - Bioactivity in the Skin","context":"DCP"},{"publicId":"3182879","version":"1","longName":"Metformin - Pre-Prostatectomy Prostate Cancer","context":"DCP"},{"publicId":"3293737","version":"1","longName":"UAB30 in NMSC","context":"DCP"},{"publicId":"3211792","version":"1","longName":"Barrett's Esophagus Chemoprevention Metformin","context":"DCP"}]},{"publicId":"2552643","version":"1","longName":"Training Class Examples","context":"Training","ClassificationSchemeItems":[{"publicId":"3637837","version":"1","longName":"Training","context":"Training"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2958139","version":"1","longName":"Common Terminology Criteria for Adverse Events v4.0","context":"CTEP"}]},{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"},{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]},{"publicId":"2964591","version":"1","longName":"Eligibility Criteria","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2965104","version":"1","longName":"Structured Eligibility Criteria","context":"NCIP"},{"publicId":"3070847","version":"1","longName":"History","context":"NCIP"}]},{"publicId":"3021954","version":"1","longName":"Caris Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3060676","version":"1","longName":"Caris Registry","context":"NCIP"}]},{"publicId":"3121334","version":"1","longName":"CTCAE v4.0 CDEs","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3121335","version":"1","longName":"CTCAEv4.0","context":"NCIP"}]},{"publicId":"3194026","version":"1","longName":"KAI Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"10000679","version":"1","longName":"Adverse Events","context":"NCIP"},{"publicId":"2812550","version":"1","longName":"General CDEs","context":"NCIP"}]},{"publicId":"3335728","version":"1","longName":"Protocols","context":"ABTC","ClassificationSchemeItems":[{"publicId":"3335732","version":"1","longName":"ABTC 0904","context":"ABTC"}]},{"publicId":"3835419","version":"1","longName":"Pharmacovigilance-Gabapentin/Pregabalin","context":"DCI","ClassificationSchemeItems":[{"publicId":"3902524","version":"1","longName":"Follow Up","context":"DCI"},{"publicId":"3835421","version":"1","longName":"Baseline","context":"DCI"}]},{"publicId":"3896529","version":"1","longName":"Consortia 2012 Studies","context":"DCP","ClassificationSchemeItems":[{"publicId":"5889177","version":"1","longName":"MDA2016-08-02","context":"DCP"},{"publicId":"4915512","version":"1","longName":"UAZ2015-05-02","context":"DCP"},{"publicId":"3896537","version":"1","longName":"UWI2013-01-02","context":"DCP"},{"publicId":"3896538","version":"1","longName":"UAZ2013-01-01","context":"DCP"},{"publicId":"3694151","version":"1","longName":"MAY2012-00-01","context":"DCP"},{"publicId":"4111771","version":"1","longName":"UWI2013-00-01","context":"DCP"},{"publicId":"4261112","version":"1","longName":"UAZ2013-02-01","context":"DCP"},{"publicId":"4261412","version":"1","longName":"MDA2013-01-01","context":"DCP"},{"publicId":"4261411","version":"1","longName":"MAY2013-01-01","context":"DCP"},{"publicId":"4188651","version":"1","longName":"MDA2013-01-02","context":"DCP"},{"publicId":"4528052","version":"1","longName":"MAY2013-02-01","context":"DCP"},{"publicId":"4528051","version":"1","longName":"MAY2013-02-02","context":"DCP"},{"publicId":"4528055","version":"1","longName":"UAZ2014-03-01","context":"DCP"},{"publicId":"4528053","version":"1","longName":"NWU2014-03-01","context":"DCP"},{"publicId":"4528056","version":"1","longName":"NWU2013-02-01","context":"DCP"},{"publicId":"5280816","version":"1","longName":"UWI2015-05-01","context":"DCP"},{"publicId":"5280817","version":"1","longName":"UWI2016-07-01","context":"DCP"},{"publicId":"4528054","version":"1","longName":"NWU2013-01-03","context":"DCP"},{"publicId":"4915511","version":"1","longName":"UAZ2015-05-01","context":"DCP"},{"publicId":"5441476","version":"1","longName":"MDA2014-04-02","context":"DCP"},{"publicId":"5416571","version":"1","longName":"MDA2013-02-02","context":"DCP"},{"publicId":"5280818","version":"1","longName":"UWI2014-03-01","context":"DCP"},{"publicId":"5592146","version":"1","longName":"MAY2015-05-01","context":"DCP"},{"publicId":"5612586","version":"1","longName":"MAY2016-07-01","context":"DCP"},{"publicId":"5598962","version":"1","longName":"MDA2014-04-01","context":"DCP"},{"publicId":"5280813","version":"1","longName":"NWU2015-06-02","context":"DCP"},{"publicId":"5280812","version":"1","longName":"NWU2015-06-01","context":"DCP"},{"publicId":"5889185","version":"1","longName":"UWI2016-08-01","context":"DCP"},{"publicId":"6005698","version":"1","longName":"MAY2017-09-01","context":"DCP"},{"publicId":"5889180","version":"1","longName":"NWU2017-09-01","context":"DCP"},{"publicId":"5889176","version":"1","longName":"MDA2016-07-02","context":"DCP"},{"publicId":"5280811","version":"1","longName":"NWU2014-04-01","context":"DCP"},{"publicId":"5889178","version":"1","longName":"MDA2017-09-03","context":"DCP"},{"publicId":"5889179","version":"1","longName":"NWU2016-08-02","context":"DCP"},{"publicId":"5280814","version":"1","longName":"NWU2015-06-03","context":"DCP"},{"publicId":"5280815","version":"1","longName":"NWU2015-06-04","context":"DCP"},{"publicId":"5889187","version":"1","longName":"UWI2017-09-01","context":"DCP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"},{"publicId":"4104900","version":"1","longName":"GOG-0277","context":"NRG"},{"publicId":"4104891","version":"1","longName":"GOG-0229N","context":"NRG"},{"publicId":"4171051","version":"1","longName":"RTOG-1016","context":"NRG"},{"publicId":"4104896","version":"1","longName":"GOG-0249","context":"NRG"},{"publicId":"4171065","version":"1","longName":"RTOG-0924","context":"NRG"},{"publicId":"4171061","version":"1","longName":"RTOG-1010","context":"NRG"},{"publicId":"4104897","version":"1","longName":"GOG-0250","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"},{"publicId":"4104890","version":"1","longName":"GOG-0229L","context":"NRG"},{"publicId":"4171062","version":"1","longName":"RTOG-1005","context":"NRG"},{"publicId":"4104993","version":"1","longName":"RTOG-1112","context":"NRG"},{"publicId":"4104892","version":"1","longName":"GOG-0229O","context":"NRG"},{"publicId":"4104941","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"10000705","version":"1","longName":"GOG-0281","context":"NRG"},{"publicId":"4104901","version":"1","longName":"GOG-0286B","context":"NRG"},{"publicId":"10000276","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104930","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"10000275","version":"1","longName":"GOG-0283","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"4058120","version":"1","longName":"GOG-0278","context":"NRG"},{"publicId":"4104996","version":"1","longName":"GOG-0279","context":"NRG"}]},{"publicId":"5635298","version":"1","longName":"All Mandatory CRF CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"5635299","version":"1","longName":"Mandatory CRF CDEs","context":"NCI Standards"}]},{"publicId":"5635300","version":"1","longName":"Case Report Form (CRF) Modules","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000681","version":"1","longName":"Adverse Events","context":"NCI Standards"}]},{"publicId":"5858960","version":"1","longName":"Adopted","context":"NRDS","ClassificationSchemeItems":[{"publicId":"5858965","version":"1","longName":"SAE","context":"NRDS"},{"publicId":"5858963","version":"1","longName":"RAVE Integrations","context":"NRDS"},{"publicId":"4861354","version":"1","longName":"caAERS","context":"NRDS"}]},{"publicId":"5858962","version":"1","longName":"Under Review","context":"NRDS","ClassificationSchemeItems":[{"publicId":"10000092","version":"1","longName":"RAVE Integrations","context":"NRDS"},{"publicId":"4861352","version":"1","longName":"CDUS","context":"NRDS"}]},{"publicId":"6147165","version":"1","longName":"Wake Forest Baptist Medical Center","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6147167","version":"1","longName":"WFB","context":"NCIP"}]}],"AlternateNames":[{"name":"CTEP","type":"USED_BY","context":"CTEP"},{"name":"DCP","type":"USED_BY","context":"DCP"},{"name":"CCR","type":"USED_BY","context":"CCR"},{"name":"Severity","type":"Screen Label","context":"NCIP"},{"name":"VALXX","type":"OID, Alliance","context":"CTEP"},{"name":"2005090","type":"COG GDE #","context":"CTEP"},{"name":"CTC_AE_GD","type":"COG GDE Short Name","context":"CTEP"},{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"AE_SEV_GD","type":"USED_BY","context":"CTEP"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"DCI","type":"USED_BY","context":"DCI"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"TOXDEG","type":"OID, SWOG","context":"SWOG"},{"name":"AE_SEV_GD","type":"USED_BY","context":"AECC"},{"name":"AE_SEV_GD","type":"USED_BY","context":"CITN"},{"name":"NRG","type":"USED_BY","context":"NRG"},{"name":"AE_SEV_GD","type":"USED_BY","context":"COG"},{"name":"Ctcae4Gd","type":"COG GDE Short Name","context":"COG"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"AE_SEV_GD","type":"USED_BY","context":"Alliance"},{"name":"AE_SEV_GD","type":"USED_BY","context":"NRG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"},{"name":"AE_SEV_GD","type":"USED_BY","context":"OHSU Knight"},{"name":"NRDS","type":"USED_BY","context":"NRDS"},{"name":"CCTG","type":"USED_BY","context":"CCTG"},{"name":"AE_SEV_GD","type":"USED_BY","context":"CCTG"},{"name":"NCIP","type":"USED_BY","context":"NCIP"},{"name":"NHLBI","type":"USED_BY","context":"NHLBI"},{"name":"AE_grade","type":"CTDC Alt Name","context":"CRDC"},{"name":"adverse_event_grade","type":"CTDC Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"CRF Text1","type":"Alternate Question Text","description":"CTC AE Grade","url":null,"context":"CTEP"},{"name":"Adverse Event Grade","type":"Preferred Question Text","description":"Adverse Event Grade","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"CTC Adverse Event Grade","url":null,"context":"CTEP"},{"name":"Severity of Adverse Event","type":"Alternate Question Text","description":"Severity of Adverse Event","url":null,"context":"NCIP"},{"name":"Mandatory NCI Standard CRF Question","type":"COMMENT","description":"Must be included on CRF when this data is collected for reporting.","url":null,"context":"NCIP"},{"name":"Grade","type":"Alternate Question Text","description":"Grade","url":null,"context":"NCIP"},{"name":"ABTC Question Text","type":"Alternate Question Text","description":"Highest grade of toxicity responsible for dose holding/reduction","url":null,"context":"CTEP"},{"name":"OHSU Text 1","type":"Alternate Question Text","description":"Grade if ongoing","url":null,"context":"OHSU Knight"},{"name":"CTCAE (4.0) Grade","type":"Alternate Question Text","description":"CTCAE (4.0) Grade","url":null,"context":"SWOG"},{"name":"DCP Text 1","type":"Alternate Question Text","description":"AE Grade","url":null,"context":"DCP"},{"name":"CRF Text 2","type":"Alternate Question Text","description":"CTCAE grade","url":null,"context":"NRG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"CTC Adverse Event Grade:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Adverse Event Grade:","url":null,"context":"COG"},{"name":"OHSU Text 2","type":"Alternate Question Text","description":"Grade, if applicable","url":null,"context":"OHSU Knight"},{"name":"ECOG CRF Text 1","type":"Alternate Question Text","description":"Worst Grade","url":null,"context":"ECOG-ACRIN"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"AE Grade:","url":null,"context":"COG"},{"name":"COG CRF Text 4","type":"Alternate Question Text","description":"Adverse event grade:","url":null,"context":"COG"},{"name":"NRG CRF_Text3","type":"Alternate Question Text","description":"NCI CTC Grade","url":null,"context":"NRG"},{"name":"COG CRF Text 5","type":"Alternate Question Text","description":"AE grade:","url":null,"context":"COG"},{"name":"NRDS Alternate Text","type":"Alternate Question Text","description":"Adverse event grade","url":null,"context":"NRDS"},{"name":"COG CRF Text 6","type":"Alternate Question Text","description":"CTCAE v5 Grade:","url":null,"context":"COG"},{"name":"CTCAE grade","type":"Application Standard Question Text","description":"CTCAE grade","url":null,"context":"NHLBI"},{"name":"COG CRF TEXT 7","type":"Alternate Question Text","description":"AE grade:","url":null,"context":"COG"},{"name":"COG CRF Text 8","type":"Alternate Question Text","description":"What was the highest grade for this AE during this Maintenance cycle?","url":null,"context":"COG"}],"origin":"CTCAE:Common TerminologyCriteria for Adverse Events","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"743D17F6-0F28-59B6-E040-BB89AD434C0F","latestVersionIndicator":"Yes","beginDate":"2009-09-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-09-23","modifiedBy":"KUMMEROA","dateModified":"2023-11-17","changeDescription":"Created to support CTCAE v4.0 release.  D. Reeves 9/22/09.  Registration is Standard based on CRF Initiative approval and alignment with BRIDG; Updated origin to support v5.0 and all other versions_02.08.18_ghd","administrativeNotes":"2023.11.17 AQT added per ticket request CADSR0003092. ak","unresolvedIssues":null,"deletedIndicator":"No"}}